These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 38734939

  • 21. Atropine 0.01% Eyedrops Significantly Reduce the Progression of Childhood Myopia.
    Clark TY, Clark RA.
    J Ocul Pharmacol Ther; 2015 Nov; 31(9):541-5. PubMed ID: 26218150
    [Abstract] [Full Text] [Related]

  • 22. Efficacy of contact lenses for myopia control: Insights from a randomised, contralateral study design.
    Weng R, Lan W, Bakaraju R, Conrad F, Naduvilath T, Yang ZK, Sankaridurg P.
    Ophthalmic Physiol Opt; 2022 Nov; 42(6):1253-1263. PubMed ID: 36006761
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Prevention of myopia onset with 0.025% atropine in premyopic children.
    Fang PC, Chung MY, Yu HJ, Wu PC.
    J Ocul Pharmacol Ther; 2010 Aug; 26(4):341-5. PubMed ID: 20698798
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Risk factors for progressive myopia in the atropine therapy for myopia study.
    Loh KL, Lu Q, Tan D, Chia A.
    Am J Ophthalmol; 2015 May; 159(5):945-9. PubMed ID: 25640408
    [Abstract] [Full Text] [Related]

  • 27. Epidemiology of myopia and prevention of myopia progression in children in East Asia: a review.
    Mak CY, Yam JC, Chen LJ, Lee SM, Young AL.
    Hong Kong Med J; 2018 Dec; 24(6):602-609. PubMed ID: 30530867
    [Abstract] [Full Text] [Related]

  • 28. Efficacy of atropine 0.01% for the treatment of childhood myopia in European patients.
    Sacchi M, Serafino M, Villani E, Tagliabue E, Luccarelli S, Bonsignore F, Nucci P.
    Acta Ophthalmol; 2019 Dec; 97(8):e1136-e1140. PubMed ID: 31197953
    [Abstract] [Full Text] [Related]

  • 29. Atropine in ameliorating the progression of myopia in children with mild to moderate myopia: a meta-analysis of controlled clinical trials.
    Song YY, Wang H, Wang BS, Qi H, Rong ZX, Chen HZ.
    J Ocul Pharmacol Ther; 2011 Aug; 27(4):361-8. PubMed ID: 21649523
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Myopia Control: A Review.
    Walline JJ.
    Eye Contact Lens; 2016 Jan; 42(1):3-8. PubMed ID: 26513719
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Atropine treatment for myopia.
    Brown SM.
    Ophthalmology; 2009 Oct; 116(10):2040; author reply 2040-1. PubMed ID: 19800530
    [No Abstract] [Full Text] [Related]

  • 38. Interventions to retard myopia progression in children: an evidence-based update.
    Saw SM, Shih-Yen EC, Koh A, Tan D.
    Ophthalmology; 2002 Mar; 109(3):415-21; discussion 422-4; quiz 425-6, 443. PubMed ID: 11874738
    [Abstract] [Full Text] [Related]

  • 39. Interventions to Reduce Myopia Progression in Children.
    Tay SA, Farzavandi S, Tan D.
    Strabismus; 2017 Mar; 25(1):23-32. PubMed ID: 28166436
    [Abstract] [Full Text] [Related]

  • 40. Reducing the progression of myopia with atropine: a long term cohort study of Olmsted County students.
    Kennedy RH, Dyer JA, Kennedy MA, Parulkar S, Kurland LT, Herman DC, McIntire D, Jacobs D, Luepker RV.
    Binocul Vis Strabismus Q; 2000 Mar; 15(3 Suppl):281-304. PubMed ID: 11486796
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.